| 标题 |
Overall survival in patients with hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer treated in a phase 1b trial evaluating gedatolisib in combination with palbociclib and endocrine therapy |
| 网址 | |
| DOI |
10.67209/olsu5373
doi
|
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)